trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['lung']
t-dxd in her2-expressing btc . intersting signal of activity in patients with high expression.
great orr 36,4% and mpfs 5.1 but mos only 7.1 mo, but 2 g5 aes, intestinal lung disease requires monitoring #cholangiocarcinoma 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine